Dofequidar

CAS : 129716-58-1

Ref. 3D-EFA71658

Informations sur le produit

• Nom: Dofequidar
• Synonymes: Dofequidar [INN], 1-(Diphenylacetyl)-4-((2RS)-2-hydroxy-3-(5-quinolyloxy)propyl)piperazine, Unii-0Bjk6B565B, 1-{4-[2-Hydroxy-3-(Quinolin-5-Yloxy)Propyl]Piperazin-1-Yl}-2,2-Diphenylethanone
• CAS: 129716-58-1

Description

Dofequidar is a pyrimidine compound that is used as an immunosuppressant drug. It is used to treat autoimmune diseases and inflammatory bowel disease. Dofequidar has been shown to inhibit the transcription-polymerase chain reaction (PCR) of T lymphocytes in vitro, which may be due to its ability to bind hydrogen bonds in DNA. Dofequidar also binds to monoclonal antibodies, including anti-CD3 and anti-CD20, and inhibits the proliferation of mouse hippocampal cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 481.59 g/mol
• Formule: C₃₀H₃₁N₃O₃
• Degré de pureté: Min. 95%